Učitavanje...

Angiotensin II type 1 receptor blocker ameliorates uncoupled endothelial nitric oxide synthase in rats with experimental diabetic nephropathy

Background Recent studies showed that angiotensin II type 1 receptor blocker (ARB) slows progression of chronic renal disease in patients with type 2 diabetes, regardless of changes in blood pressure. We showed that the imbalance of nitric oxide (NO) and reactive oxygen species (ROS) due to endothel...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Glavni autori: Satoh, Minoru, Fujimoto, Sohachi, Arakawa, Sayaka, Yada, Toyotaka, Namikoshi, Tamehachi, Haruna, Yoshisuke, Horike, Hideyuki, Sasaki, Tamaki, Kashihara, Naoki
Format: Artigo
Jezik:Inglês
Izdano: Oxford University Press 2008
Teme:
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC2639062/
https://ncbi.nlm.nih.gov/pubmed/18596126
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/ndt/gfn357
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!